Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Advantage: Convenient, familiar, non-invasive Challenge: Peptides face proteolytic degradation in the stomach and small intestine Bioavailability: Estimated at approximately 38% based on comparative pharmacology (see below) Transdermal (Patch) Some researchers have explored transdermal patches to deliver peptides: Advantage: Avoids first-pass metabolism and GI degradation Challenge: Intact skin is a strong barrier to peptide penetration Feasibility: Not commonly available commercially
Its short peptide structure makes it a recognised compound within sequence based research discussions
It simply means your body may benefit more from pre-methylated forms of folate and B12
Why does the injectable dose look twenty times smaller than the capsule dose?+ Because it is a different route, not a different strength
Dozens of websites selling BPC-157 can be found via a quick Google search
The theoretical oncogenic risk is a significant unresolved safety question for any long-term human application
US$ 29.72
US$ 20.81
US$ 28.89
